IMNM vs VRTX: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Vertex Pharmaceuticals Inc in 2026
IMNM
Immunome Inc
$22.90
VRTX
Vertex Pharmaceuticals Inc
$444.28
Key Metrics Comparison
| Metric | IMNM | VRTX | Winner |
|---|---|---|---|
| Market Cap | $2.56B | $111.93B | VRTX |
| P/E Ratio | N/A | 28.74 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | -1.0% | 0.1% | VRTX |
| Gross Margin | -2454.2% | 53.7% | VRTX |
Analyze IMNM
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or VRTX a better investment?
Comparing IMNM and VRTX: Immunome Inc has a market cap of $2.56B while Vertex Pharmaceuticals Inc has $111.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and VRTX?
IMNM (Immunome Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or VRTX?
VRTX has higher revenue growth at 0.1% vs -1.0% for IMNM.
Which company is more profitable: IMNM or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -2454.2% for IMNM.
Which is the larger company: IMNM or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.93B compared to $2.56B for IMNM.
Should I buy IMNM or VRTX in 2026?
Both IMNM and VRTX have investment merit. IMNM trades at $22.90 while VRTX trades at $444.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and VRTX stock?
Key differences: Market Cap ($2.56B vs $111.93B), P/E Ratio (N/A vs 28.7x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (-2454.2% vs 53.7%).